250 related articles for article (PubMed ID: 23378459)
21. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
[TBL] [Abstract][Full Text] [Related]
22. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR
Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
24. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133
[TBL] [Abstract][Full Text] [Related]
25. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
26. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A; Chayoua W; de Laat B; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ
J Thromb Haemost; 2022 Sep; 20(9):2136-2150. PubMed ID: 35713971
[TBL] [Abstract][Full Text] [Related]
27. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
28. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
[TBL] [Abstract][Full Text] [Related]
29. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
[TBL] [Abstract][Full Text] [Related]
30. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
[TBL] [Abstract][Full Text] [Related]
31. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?
Lee EY; Lee CK; Lee TH; Chung SM; Kim SH; Cho YS; Yoo B; Moon HB
Thromb Res; 2003; 111(1-2):29-32. PubMed ID: 14644075
[TBL] [Abstract][Full Text] [Related]
32. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
33. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β
Nakamura H; Oku K; Amengual O; Ohmura K; Fujieda Y; Kato M; Bohgaki T; Yasuda S; Atsumi T
Arthritis Care Res (Hoboken); 2018 Apr; 70(4):627-634. PubMed ID: 28686816
[TBL] [Abstract][Full Text] [Related]
34. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
35. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
36. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.
Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Kitani T; Iwatani Y; Kanakura Y
Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993
[TBL] [Abstract][Full Text] [Related]
37. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
[TBL] [Abstract][Full Text] [Related]
38. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.
Hanly JG; Smith SA
Clin Exp Immunol; 2000 Jun; 120(3):537-43. PubMed ID: 10844535
[TBL] [Abstract][Full Text] [Related]
39. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
Demir S; Li J; Magder LS; Petri M
Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
[TBL] [Abstract][Full Text] [Related]
40. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]